期刊文献+

临床药师参与1例肺移植患者个体化治疗的药学实践 被引量:4

Pharmaceutical Practice of Individualized Treatment for a Patient after Lung Transplantation by Clinical Pharmacist
原文传递
导出
摘要 目的以1例百草枯中毒后肺移植患者为例,探讨临床药师在肺移植术后患者个体化治疗中的作用。方法临床药师全程参与肺移植术后患者的治疗并进行全方位的药学监护,根据患者病情变化和治疗药物监测结果调整优化给药方案、注意药物相互作用、关注药物疗效及不良反应、提供患者用药教育等。结果通过对患者治疗方案的优化,感染得到有效控制;他克莫司血药浓度维持在有效治疗窗范围内,避免了严重不良反应的发生。对患者用药教育的实施,提高了患者用药依从性。结论临床药师深入临床,对肺移植术后患者实施药学监护,有利于促进合理用药,并提高患者用药安全性和有效性。 OBJECTIVE To explore the role of clinical pharmacist in the individualized treatment for lung transplantation patients, using a case of lung transplantation patient after paraquat poisoning. METHODS Clinical pharmacist was involved in the treatment of lung transplant recipient and provided the full range of clinical pharmacy services, by adjusting and optimizing the medication regimen according to the patient′s condition and the monitoring results of therapeutic drug, paying attention to drug interaction, drug efficacy, adverse reactions and providing education of patient medication. RESULTS The infection was effectively controlled and the blood concentration of tacrolimus was maintained within the effective treatment window which avoided the serious adverse reactions, by optimizing the treatment plan. The medication adherence was improved by providing medication education for patient. CONCLUSION It is beneficial to promote rational drug use and improve the safety and effectiveness of the drug treatment for clinical pharmacist to go into clinical practice, and carry out pharmaceutical care for lung transplant recipient.
作者 李纳 刘楠 汤姝 孟海阳 张晓坚 LI Na;LIU Nan;TANG Shu;MENG Hai-yang;ZHANG Xiao-jianDepartment of Pharmacy(Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052 , China)
出处 《中国药学杂志》 CAS CSCD 北大核心 2019年第10期834-838,共5页 Chinese Pharmaceutical Journal
关键词 临床药师 肺移植 药学监护 clinical pharmacist lung transplantation pharmaceutical care
  • 相关文献

参考文献3

二级参考文献53

  • 1贾晋生,武丽娟,李雪琴.抗菌药物相关性腹泻的诊断[J].中华医院感染学杂志,2005,15(8):872-872. 被引量:6
  • 2Van Mourik ID, Kelly DA. Immunosuppressive drugs in paediatric liver transplantation. Paediatr Drugs, 2001,3 (1) : 43 -60.
  • 3Van Gelder T. Drug interactions with tacrolimus. Drug Saf, 2002, 25(10) : 707 -712.
  • 4Maes B, Hadaya K, de Moor B, et al. Severe diarrhea in renal transplant patients : results of the DIDACT study. Am J Transplant, 2006, 6(6) :1466 - 1472.
  • 5Givon-Lavi N, Greenberg D, Dagan R. Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children. Vaccine, 2008, 26(46) : 5798 -5801.
  • 6Heller T, van Gelder T, Budde K, et al. Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients. Am J Transplant, 2007, 7 (7) : 1822 - 1831.
  • 7Lemahieu W, Maes B, Verheke K, et al. Cytochrome P450 3A4 and P-glyeoprotein Activity and Assimilation of Taerolimus in Transplant Patients with Persistent Diarrhea. Am J Transplant, 2005, 5 ( 6 ) : 1383 - 1391.
  • 8Hochleitner BW, Bosmiiller C, Nehoda H, et al. Increased tacrolimus levels during diarrhea. Transpl Int, 2001,14 (4) : 230 - 233.
  • 9Teisseyre J, Teisseyre M, Kalicinski P, et al. Elevated taerolimus levels during diarrhea in children after liver transplantation. Transplant Proc, 2003, 35 (6) : 2292 - 2294.
  • 10Tuteja S, Alloway RR, Johnson JA, et al. The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients. Transplantation, 2001, 71 (9) : 1303 - 1307.

共引文献46

同被引文献50

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部